UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 25
NOTIFICATION OF REMOVAL FROM LISTING AND/OR
REGISTRATION UNDER SECTION 12(b) OF THE
SECURITIES EXCHANGE ACT OF 1934.
Commission File Number 001-32654
AnorMED Inc.
(Exact name of Issuer as specified in its charter, and name of Exchange where security is listed and/or registered)
200 – 20353 64th Avenue, Langley, British Columbia, Canada V2Y 1N5, (604) 530-1057
(Address, including zip code, and telephone number, including area code, of Issuer’s principal executive offices)
Common Shares
(Description of class of securities)
Please place an X in the box to designate the rule provision relied upon to strike the class
of securities from listing and registration:
o 17 CFR 240.12d2-2(a)(1)
o 17 CFR 240.12d2-2(a)(2)
o 17 CFR 240.12d2-2(a)(3)
o 17 CFR 240.12d2-2(a)(4)
o Pursuant to 17 CFR 240.12d2-2(b), the Exchange has complied with its rules to strike the class
of securities from listing and/or withdraw registration on the Exchange. 1
þ Pursuant to 17 CFR 240.12d2-2(c), the Issuer has complied with the rules of the Exchange
and the requirements of 17 CFR 240.12d2-2(c) governing the voluntary withdrawal of the class of
securities from listing and registration on the Exchange.
Pursuant to the requirements of the Securities Exchange Act of 1934, AnorMED Inc. (Name of
Issuer or Exchange) certifies that it has reasonable grounds to believe that it meets all of the
requirements for filing the Form 25 and has caused this notification to be signed on its behalf by
the undersigned duly authorized person.
Date: September 7, 2006
| |
|
|
|
|
| |
|
|
| |
By: |
/S/ WILLIAM J. ADAMS
|
|
| |
|
William J. Adams |
|
| |
|
Chief Financial Officer, Vice President, Finance,
Secretary and Treasurer |
|
| |
|
|
|
| 1 |
|
Form 25 and attached Notice will be considered compliance with the
provisions of 17 CFR 240.19d-1 as applicable. See General Instructions. |